These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34185909)

  • 1. Progress in Drug Development-Pediatric Dose Selection: Workshop Summary.
    Wang J; van den Anker JN; Burckart GJ
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S13-S21. PubMed ID: 34185909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Call for Objective Dose Selection to Increase Success in Pediatric Clinical Trials: A Perspective From NICHD and NIMH Program Staff.
    Giacoia G; Grabb MC; Pawlyk AC; Ren Z; Samedy-Bates L; Taylor-Zapata P
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S9-S12. PubMed ID: 34185908
    [No Abstract]   [Full Text] [Related]  

  • 3. The European Medicines Agency Experience With Pediatric Dose Selection.
    Manolis E; Musuamba FT; Karlsson KE
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S22-S27. PubMed ID: 34185894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods Used for Pediatric Dose Selection in Drug Development Programs Submitted to the US FDA 2012-2020.
    Green FG; Park K; Burckart GJ
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S28-S35. PubMed ID: 34185898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-Informed Pediatric Drug Development: Application of Pharmacometrics to Define the Right Dose for Children.
    Vinks AA; Barrett JS
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S52-S59. PubMed ID: 34185897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal and Pediatric Dose Selection: Quo Vadis?
    Burckart GJ; van den Anker JN
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S7-S8. PubMed ID: 34185900
    [No Abstract]   [Full Text] [Related]  

  • 7. Minors and a Dawning Paradigm Shift in "Pediatric" Drug Development.
    Rose K; Tanjinatus O; Grant-Kels JM; Ettienne EB; Striano P; Neubauer D
    J Clin Pharmacol; 2021 Jun; 61(6):736-739. PubMed ID: 33368372
    [No Abstract]   [Full Text] [Related]  

  • 8. Real-World Data for Pediatric Pharmacometrics: Can We Upcycle Clinical Data for Research Use?
    Van Driest SL; Choi L
    Clin Pharmacol Ther; 2019 Jul; 106(1):84-86. PubMed ID: 30942897
    [No Abstract]   [Full Text] [Related]  

  • 9. Adolescents and Drug Development: Commentary on a Dawning Paradigm Shift.
    Kearns GL; van den Anker JN
    J Clin Pharmacol; 2021 Jun; 61(6):740-743. PubMed ID: 33797778
    [No Abstract]   [Full Text] [Related]  

  • 10. Status Toward the Implementation of Precision Dosing in Children.
    Barrett JS; Barrett RF; Vinks AA
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S36-S51. PubMed ID: 34185896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosing Recommendations for Pediatric Patients With Renal Impairment.
    Al-Khouja A; Park K; Anderson DJC; Young C; Wang J; Huang SM; Khurana M; Burckart GJ
    J Clin Pharmacol; 2020 Dec; 60(12):1551-1560. PubMed ID: 32542790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic Evaluation in Pregnancy-Current Status and Future Considerations: Workshop Summary.
    Guinn D; Sahin L; Fletcher EP; Choi SY; Johnson T; Dinatale M; Baisden K; Sun W; Pillai VC; Morales JP; Yao L
    J Clin Pharmacol; 2023 Jun; 63 Suppl 1():S7-S17. PubMed ID: 37317499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Industry Perspective on Using MIDD for Pediatric Studies Requiring Integration of Ontogeny.
    Corriol-Rohou S; Cheung SYA
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S112-S119. PubMed ID: 31502694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Safety in Labeling for Pediatric Drug Development and Dose Selection in Submissions to the US Food and Drug Administration.
    Kim C; Park K; McMahon AW; Green FG; Green DJ; Burckart GJ
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S133-S140. PubMed ID: 34185899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric formulation development - Challenges of today and strategies for tomorrow: Summary report from M-CERSI workshop 2019.
    Tan DCT; Khong YM; Mount S; Galella E; Mitra B; Charlton S; Kuhli M; Ternik R; Walsh J; Rajapakshe A; Thompson K; Mehrotra S; Santangelo M; Liu J; Dixit T; Schaufelberger D; Jamzad S; Klein S; Hoag SW; Wang J; Fletcher EP; Khurana M; Alexander J; Radden E; Sood R; Selen A
    Eur J Pharm Biopharm; 2021 Jul; 164():54-65. PubMed ID: 33878432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Precision Medicine on Efficiencies of Novel Drug Development in Cancer.
    Sarvas H; Carlisle B; Dolter S; Vinarov E; Kimmelman J
    J Natl Cancer Inst; 2020 Aug; 112(8):859-862. PubMed ID: 31722417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model-Informed Drug Development: A Regulatory Perspective on Progress.
    Zhu H; Huang SM; Madabushi R; Strauss DG; Wang Y; Zineh I
    Clin Pharmacol Ther; 2019 Jul; 106(1):91-93. PubMed ID: 31162631
    [No Abstract]   [Full Text] [Related]  

  • 18. Physiologically Based Pharmacokinetic Modeling in Pediatric Oncology Drug Development.
    Rioux N; Waters NJ
    Drug Metab Dispos; 2016 Jul; 44(7):934-43. PubMed ID: 26936973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings of a Workshop: US Food and Drug Administration-International Society of Pharmacometrics Model-Informed Drug Development in Oncology.
    Bruno R; Jin JY; Maxfield K; Milligan L; Liu C; Wang Y; McKee AE; Zineh I
    Clin Pharmacol Ther; 2019 Jul; 106(1):81-83. PubMed ID: 30951201
    [No Abstract]   [Full Text] [Related]  

  • 20. Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson ADJ; Zwaan CM; Kolb EA; Karres D; Guillot J; Kim SY; Marshall L; Tasian SK; Smith M; Cooper T; Adamson PC; Barry E; Benettaib B; Binlich F; Borgman A; Brivio E; Capdeville R; Delgado D; Faller D; Fogelstrand L; Fraenkel PG; Hasle H; Heenen D; Kaspers G; Kieran M; Klusmann JH; Lesa G; Ligas F; Mappa S; Mohamed H; Moore A; Morris J; Nottage K; Reinhardt D; Scobie N; Simko S; Winkler T; Norga K; Reaman G; Vassal G
    Eur J Cancer; 2020 Sep; 136():116-129. PubMed ID: 32688206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.